BUSINESS COMBINATION AGREEMENT WITH POWERUP ACQUISITON CORP (Details Narrative) $ in Millions	Dec. 31, 2024 USD ($)
Aspire Biopharma Inc [Member]
Transaction costs	$ 316.8

Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.

No definition available.

Name:	us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant